Definitive Contract W911QY20C0003
Award Date
10/30/19
Potential Completion Date
5/3/22
Potential Value
$1.5M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
CMC Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cleveland, OH 44103, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $149,268.80 Small Business Innovation Research (SBIR) Program Phase I contract to CMC Pharmaceuticals, Inc., a woman-owned small business. This firm fixed price contract is for research and development related to a SBIR topic on chemical/biological defense. As a small business, CMC Pharmaceuticals will provide drug formulation development and complex drug delivery system services to...
This firm fixed-price purchase order was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to CMC Pharmaceuticals, Inc., a woman-owned small business, under the Small Business Innovation Research (SBIR) Program. The $167,076.48 contract is for Phase I research and development to formulate and develop manufacturing processes for a multi-dose vial presentation of scopolamine hydrobromide trihydrate containing antimicrobial preservatives....
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1.1 million firm fixed price contract to CMC Pharmaceuticals, Inc. doing business as CMC Pharmaceuticals Inc. as part of the Small Business Innovation Research Program Phase II action. The contract will fund continued research and development efforts by CMC Pharmaceuticals Inc. at their facility located in Solon, Ohio from September 2022 through September 2024. The contract was awarded on a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $11,587.21. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military...
This is a $493,602.59 Cost Plus Fixed Fee Definitive Contract awarded by the Department of the Army Medical Command to Management Sciences Inc., a woman-owned small business. The contract is for SBIR Phase III research and development under DARPA Topic #SB093-004 to develop medical situation awareness systems for the military. As a prime contractor, Management Sciences Inc. has extensive experience supporting federal agencies with a range of products and services, including sensor fusion,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) valued at up to $499,999,999. The IDC, known as SPE2DB, covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The specific award, valued at $1,626.26, is for the supply of fluticasone propionat to the DLA's...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order with a ceiling value of $1,326.18. The contract is for the supply of various pharmaceutical products, including medications such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. These products are primarily delivered to the Defense Logistics Agency (DLA)...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order worth $1,492.79. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract covers the delivery of various pharmaceutical items, including medications like flumazenil injections,...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,997.56 contract is for the delivery of pharmaceutical products, including a suspension medication, to support the medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $2,687.00 firm fixed-price contract is for the supply of a pharmaceutical product, Cyanokit 5 gram vials, with a period of performance through September 4, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...